✦ LIBER ✦

Efficacy and safety of long-term low molecular weight heparin in patients with antiphospholipid syndrome

✍ Scribed by Vargas-Hitos, J. A.; Ateka-Barrutia, O.; Sangle, S.; Khamashta, M. A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antiphospholipid syndrome, long-term tre

✍ M.G. Genievskaya; A.D. Makatsaria 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 158 KB

Long-duration therapy with low molecular

✍ F. DENTALI; E. MANFREDI; M. CROWTHER; W. AGENO 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

Thromboprophylaxis with low-molecular we

✍ S.G. Ismailova; V.O. Bitsadze; A.D. Makatsaria 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 160 KB

022: Compared efficacy and safety of unf

✍ Majed Hassine, Mohamed; Selmi, Wiem; Ben Messaoud, Mejdi; Ghrissi, Ismail; Karou 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 61 KB

Efficacy and safety of rivaroxaban versu

✍ Long, Anhua; Zhang, Lihai; Zhang, Yingze; Jiang, Baoguo; Mao, Zhi; Li, Hongda; Z 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 190 KB

Efficacy and safety of low molecular wei

✍ Caldeira, D.; David, C.; Santos, A. T.; Costa, J.; Pinto, F. J.; Ferreira, J. J. 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 322 KB